Mark E. Delaney - 12 May 2025 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Reporting relationship: SVP & Chief Commercial Officer
Issuer ticker: DGX
Reported as of: 12 May 2025
Net transaction value: -$306,800
SEC form: 4
Accepted by SEC: 14 May 2025, 17:12:30 UTC
Prior SEC filing: 02 May 2025
Next SEC filing: 25 Jul 2025
Source filing: View source filing
Reporting owner signature: Sean D. Mersten, Attorney in Fact for Mark E. Delaney

Key filing fact

Mark E. Delaney filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 14 May 2025.

Key facts

This page summarizes Mark E. Delaney's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 14 May 2025, 17:12.

Change

Previous filing in this sequence was filed on 02 May 2025.
Current net transaction value: -$306,800.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001955265 Primary reporting owner

DELANEY MARK E

Relationship: SVP & Chief Commercial Officer
Address: 500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS
Signature: Sean D. Mersten, Attorney in Fact for Mark E. Delaney
Signature date: 14 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DGX transaction

Common Stock

Sale

Transaction value: $153,579
Shares: -874
Change %: -9.5%
Price: $175.72
Shares after: 8,372
Date: 12 May 2025
Ownership: Direct
Footnotes: F1

DGX transaction

Common Stock

Sale

Transaction value: $153,221
Shares: -874
Change %: -10%
Price: $175.31
Shares after: 7,498
Date: 13 May 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.